AM3 + antioxidants
AM3 + antioxidants has been studied in 1 paper since 2023: 1 trial in people. The newest paper, Dec 8, 2023: “Immunomodulation with AM3 and antioxidants creates an adequate framework for skin repair and decreases the monocyte proinflammatory stage in smoker women”.
1 paper studies it5 findingsUpdated
“AM3 plus antioxidants treatment compared with placebo significantly reduced the monocyte production of the proinflammatory interleukin 1 (IL-1), tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) cytokines”
- 1 lab in 1 country
- Funder: European Research Council
- 5 of 5 findings with company ties
- Human trial1
What did studies of AM3 + antioxidants find?
5Studies of AM3 + antioxidants measured 5 outcomes; the most studied are phagocytic activity (1 study), oxidative stress and ROS signaling (1) and reticular dermis depth (1).
Phagocytic activity
upin humans1
1 study
Phagocytic activity
upin humans1
AM3 + antioxidants increase phagocytic activity in humans.
“increased their phagocytic activity”
Human trialhealthy smoker womenthree monthsfemalesn = 32
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Oxidative stress and ROS signaling
no changein humans1
1 study
Oxidative stress and ROS signaling
no changein humans1
AM3 + antioxidants have no effect on oxidative stress and ROS signaling in humans.
“AM3 and antioxidants did not modify ROS production by monocytes and granulocytes”
Human trialhealthy smoker womenthree monthsfemalesn = 32
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Reticular dermis depth
upin humans1
1 study
Reticular dermis depth
upin humans1
AM3 + antioxidants increase reticular dermis depth in humans.
“The active combination also stimulated a significative increase in reticular dermis depth”
Human trialhealthy smoker womenskinthree monthsfemalesn = 32
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
IL-10
upin humans1
1 study
IL-10
upin humans1
AM3 + antioxidants increase IL-10 in humans.
“as well as increased the regulatory IL-10 in middle-aged smoker women”
Human trialhealthy smoker womenthree monthsfemalesn = 32
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Inflammation
downin humans1
1 study
Inflammation
downin humans1
AM3 + antioxidants decrease inflammation in humans.
“AM3 plus antioxidants treatment compared with placebo significantly reduced the monocyte production of the proinflammatory interleukin 1 (IL-1), tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) cytokines”
Human trialhealthy smoker womenthree monthsfemalesn = 32
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie